Healthcare -
Biotechnology - NASDAQ - US
$ 21.93
1.2 %
$ 3.16 B
Market Cap
-7.95
P/E
DNLI - SHORT-TERM DEBT
Short-term Debt DNLI - Denali Therapeutics Inc.
7.26 M
LAST VALUE
15.39%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR